VIFOR-PHARMA
Regulatory News:
THE 2018 IRON DEFICIENCY DAY IS A CALL FOR PEOPLE AROUND THE WORLD TO GET IRON- INFORMED AND TO UNDERSTAND WHY IRON IS IMPORTANT FOR THE BODY AND WHAT CAN HAPPEN IF IRON LEVELS ARE NOT PROPERLY MANAGED. IRON DEFICIENCY REMAINS AN UNDER-RECOGNISED AND UNDERESTIMATED CONDITION DESPITE ITS POTENTIALLY SERIOUS CONSEQUENCES AND RELATIVELY HIGH PREVALENCE.6, 7
Although iron deficiency can affect anyone, it is most prevalent in premenopausal women, pregnant woman and children under five years of age3 . Iron deficiency, left untreated, can develop into iron deficiency anaemia. The effects of iron deficiency differ from person to person, but they can be linked to an overall decline in general health and well-being.13 Even without anaemia, iron deficiency can be debilitating, exacerbate an underlying chronic disease and lead to increased morbidity and mortality.4 If the condition develops, common symptoms include fatigue,5, 9, 10 pale skin,5 brittle nails,5, 11 craving non-food items such as dirt, clay and ice5, 12 and an inability to concentrate.9, 13 However, the symptoms of iron deficiency can manifest in different ways; they are hard to pinpoint and can be associated with a number of other health conditions.4,5 In children specifically, iron deficiency can significantly impair cognitive and motor development.14
Not recognising the symptoms of iron deficiency and iron deficiency anaemia is often the biggest contributor to not seeking – and receiving – a diagnosis.4 Learning to identify the symptoms is an important step towards finding the diagnosis. The new Iron Deficiency Day Symptom Checker will use animations to elucidate the effects of iron deficiency and iron deficiency anaemia in order to educate people in recognising the condition.
Dr. Diana Mansour, Consultant in Community Gynaecology and Reproductive Health Care and Head of Sexual Health Services at New Croft Centre in Newcastle, United Kingdom, said: “Iron deficiency affects so many women across the world and can have a significant impact on their health and quality of life. Maintaining iron levels is particularly important in pregnant women, as it can affect not only a woman’s health, but also the development of her unborn child. It is vital that we encourage women to recognise the symptoms of iron deficiency so that they can talk to their healthcare providers and start to access the support they need to manage their iron levels effectively.”
Prof Michal Matysiak, Department of Paediatrics, Haematology and Oncology, Medical University of Warsaw, Poland stresses the point that there’s a real need to raise awareness of the serious consequences of iron deficiency. “Even though it can have a major impact on a child’s development, iron deficiency remains underdiagnosed and undertreated. This disease is the number one nutritional deficiency globally. Greater awareness of iron deficiency and an understanding of its symptoms would help correct that problem.”
Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. Vifor Pharma Group is headquartered in Switzerland and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348). For more information, please visit www.viforpharma.com .
Iron Deficiency Day takes place every year on 26 November and is dedicated to:
- raising awareness of the serious public health problem iron deficiency poses.1
- highlighting the significant impact iron deficiency and iron deficiency anaemia can have on the lives of those living with it.1
- helping people recognise the common and often overlooked symptoms.
To help people around the world get iron informed, Iron Deficiency Day 2018 has developed a range of information and materials to help people understand iron deficiency and iron deficiency anaemia and a Symptom Checker to help people recognise the numerous but varied symptoms. The Symptom Checker lists the main symptoms associated with iron deficiency and iron deficiency anaemia and brings them to life with an animated character, to further explain each symptom.
Iron deficiency is very common present in one-third of people around the world.2 It is most prevalent in premenopausal and pregnant women and children under the age of five.3 In Europe for example, iron deficiency affects up to 33% of pre-menopausal women, up to 77% of pregnant women, and up to 48% of children3 . Iron deficiency is also frequently associated with chronic inflammatory diseases such as chronic heart failure, chronic kidney disease and irritable bowel disease.4
Iron is required throughout the body. It is essential for the production of red blood cells, and ensuring that the heart and skeletal muscles can function effectively.15 Iron also plays a vital role in fighting off infections and illness,16 maintaining energy levels16 and normal brain function.17 When the body’s available iron stores are low (iron deficiency) it can impact almost all aspects of life such as metabolism, mental and physical health, work productivity and even sexual function.5, 17 The World Health Organization states that iron deficiency can lead to a reduction of 30% in physical work output.18
For more information visit www.irondeficiencyday.com .
References
- Hassan, Tamer Hasan et al. “Impact of Iron Deficiency Anemia on the Function of the Immune System in Children.” Ed. Esaki M. Shankar. Medicine 95.47 (2016): e5395. PMC . Web. 12 June 2018.
- Peyrin-Biroulet L, et al. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr . 2015;102(6):1585-94.
- Hercberg S, et al. Iron deficiency in Europe. Public Health Nutr . 2007;4(2b).
- Cappellini MD et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol . 2017 Oct;92(10):1068-1078.
- Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol . 2016;91(1):31-38.
- Thachil J. Iron deficiency: still under-diagnosed? Br J Hosp Med . 2015;76(9):528-532.
- Miller JL. Anemia: a common and curable disease. Cold Spring Harb Perspect Med . 2013 Jul; 3(7).
- Caramelo L, Mezzacasa A and Kassebaum NJ. Iron Deficiency. Understanding perceptions of sufferers and the general public. EHA 21st Annual Congress, 9-12 June 2016, Copenhagen, Denmark.
- Fernando B, et al. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol. 2009 Oct 7; 15(37): 4638-4643.
- Favrat, B., et al. (2014). Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study. PLoS One 9(4): e94217. eCollection 2014. <
- Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol . 2010;28(4):420-5.
- Barton JC, et al. Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients. BMC Blood Disord. 2010;10:9. doi:10.1186/1471-2326-10-9.
- Patterson A et al. Iron deficiency, general health and fatigue: Results from the Australian Longitudinal Study on Women’s Health. Qual Life Res . 2000;9:491-497.
- World Health Organisation. Nutritional anaemias: tools for effective prevention and control. 2017. Available at URL: http://www.who.int/nutrition/publications/micronutrients/anaemias-tools-prevention-control/en/ . Last accessed: June 2018.
- Camaschella C. 2015. Iron‐deficiency anemia. N. Engl. J. Med . 372:1832–1843.
- Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr . 2001:568-580.
- Pinero DJ, Connor JR. Iron in the Brain: An Important Contributor in Normal and Diseased States. Neurosci . 2000;6(6):435-453.
- World Health Organisation. Iron deficiency anaemia. Assessment, prevention and control: A guide for programme managers. 2001. Available at URL: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf Last accessed: June 2018.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181125005128/en/
Contact:
Media Relations Heide Hauer Head of Corporate Communications Tel.: +41 58 851 80 87 E-mail: media@viforpharma.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte
You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release
More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release
Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System30.5.2025 06:08:00 CEST | Press release
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom